Stock NWRN NEWRON PHARMACEUTICALS S.P.A.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Newron Pharmaceuticals S.p.A.

Equities

NWRN

IT0004147952

Market Closed - Swiss Exchange
Other stock markets
 11:30:11 2024-04-19 am EDT 		5-day change 1st Jan Change
6.95 CHF +4.04% Intraday chart for Newron Pharmaceuticals S.p.A. -5.44% +40.40%
Apr. 17 Newron Pharmaceuticals Appoints Margarita Chavez as Independent Board Member CI
Mar. 19 Newron Pharmaceuticals S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Evolution of the average Target Price on Newron Pharmaceuticals S.p.A.

Price target over the last 5 years

History of analyst recommendation changes

5.QNRJ3jez3Ibam8t7R3okVxqhmOW4RSSFc_fWMj8Qvas.OZwgukXW7u_rr5QXHitzGnWY9aCIIHTsQ7mFU3x56sRzmiOnZsu0y7_eng~37a71122442a051ab0d1114b1ffa7a5f

Analyst Recommendations on Newron Pharmaceuticals S.p.A.

Swiss Equities Edge Higher as Markets Continue to Weigh Rate Cut Outlook MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
7.169 EUR
Average target price
13.28 EUR
Spread / Average Target
+85.27%
High Price Target
14.11 EUR
Spread / Highest target
+96.78%
Low Price Target
12.75 EUR
Spread / Lowest Target
+77.88%

Consensus detail

Consensus revision (last 18 months)

Ratings for Newron Pharmaceuticals S.p.A.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. NWRN Stock
  4. Consensus Newron Pharmaceuticals S.p.A.